D-Melibiose [585-99-9]
Cat# T2914-100mg
Size : 100mg
Brand : TargetMol
D-Melibiose
(Synonyms: Melibiose, Galalpha1-6Glcbeta) Copy Product InfoD-Melibiose (Galalpha1-6Glcbeta) is a reducing disaccharide formed by an alpha-1, 6 linkage between galactose and glucose (D-Gal-α(1→6)-D-Glc).
Select Batch
Purity:99.65%
Appearance:Solid
Color:White
COA HNMR LCMS
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | D-Melibiose (Galalpha1-6Glcbeta) is a reducing disaccharide formed by an alpha-1, 6 linkage between galactose and glucose (D-Gal-α(1→6)-D-Glc). |
| Synonyms | Melibiose, Galalpha1-6Glcbeta |
| Molecular Weight | 342.30 |
| Formula | C12H22O11 |
| Cas No. | 585-99-9 |
| Smiles | O(C[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O |
| Relative Density. | 1.68 g/cm3 (Predicted) |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 62.5 mg/mL (182.59 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.84 mM), Sonication is recommended. 10% DMSO+90% Saline: 6.25 mg/mL (18.26 mM), Solution. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||





